About OneSource Specialty Pharma Ltd
OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics.
Founded
2007
CEO
Arun Kumar
Employees
1,773
HQ
Bengalooru, India
Finished Products
1Sale of Services
₹843.77Cr2Sale of goods
₹627.74CrRaw Materials
1Cost of Materials Consumed
₹476.08CrAbout OneSource Specialty Pharma Ltd
OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics.
Founded:2007
CEO:Arun Kumar
Employees:1,773
HQ:Bengalooru, India
Finished Products
1Sale of Services
₹843.77Cr2Sale of goods
₹627.74CrRaw Materials
1Cost of Materials Consumed
₹476.08CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,925
52W Low
₹1,057
Volume136.29K
Avg VolumeN/A
Beta-0.23
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-359.96x
Valuation
P/B Ratio
3.00x
Valuation
EPS
₹-4.24
Valuation
Dividend Yield
0.00%
Valuation
ROE
-1.10%
Profitability
ROCE
0.55%
Profitability
Revenue by Segment
Contribution & growth by business line
CDMO
+740.4%100.0%
₹1,444.85 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
13.4%
International
86.6%
Rest of the world39.4%
United States of America (USA)35.0%
India13.4%
Ireland12.1%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.26x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
234.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.